𝔖 Bobbio Scriptorium

✦ LIBER ✦

145 Drug-resistant HIV-1 mutants may undergo further mutations in their reverse transcriptase (RT) under continuous pressure of HIV-1-specific RT inhibitors: J. Balzarini,1 A. Karlsson2 and E. De Clercq1 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium and 2Department of Biochemistry I, Karolinska Institute, S-104 01 Stockholm, Sweden

Book ID: 118393590
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 90 KB
Volume: 23
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90268-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The thiocarboxanilides UC-781 and UC-82

The thiocarboxanilides UC-781 and UC-82 are potent HIV-1-specific reverse transcriptase inhibitors that inhibit a broad spectrum of drug-resistant HIV-1 strains: J. Balzarini1, C.-F. Perno2, D. Schols1, M. Witvrouw1, E. De Clercq1 and A. Karlsson3 1Rega Institute for Medical Research, K.U.Leuven, Leuven, Belgium; 2University of Rome “Tor Vergata”, Rome, Italy; 3Karolinska Institute, Stockholm, Sweden

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 111 KB

93 Human immunodeficiency virus type 1 (

93 Human immunodeficiency virus type 1 (HIV-1) mutant strains emerging after combination of HIV-1-specific inhibitors in cell culture: J. Balzarini1, A. Karlsson2, M.-J. Pérez-Pérez3, M.-J. Camarasa3 and E. De Clercq1 1Rega Institute for Medical Research, K.U.Leuven, B-3000 Leuven, Belgium; 2Karolinska Institute, Biochemistry I, Box 60400, S-104 01 Sweden; 3Instituto de Quimica Medica, 28600 Madrid, Spain

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 72 KB

140 Effects of combinations of HIV-1 spe

140 Effects of combinations of HIV-1 specific RT inhibitors with complementary resistance profiles on the time and type of drug-resistant HIV-1 development: R. Pauwels1, M.P. de Béthune1, K. Andries2, P. Stoffels2, J. Desmyter1, P.A.J. Janssen2 and E. De Clercq1 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium and 2Janssen Research Foundation, Beerse, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 81 KB

HIV-1 specific phenylacetamide derivativ

HIV-1 specific phenylacetamide derivatives: A novel class of reverse transcriptase inhibitors with potent and selective antiviral activity in vitro : R. Pauwels1, K. Andries2, Z. Debyser1, P. Van Daele2, D. Schols1, M.A.C. Janssen2, J. Desmyter1, E. De Clercq1 and P.A.J. Janssen2 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium and 2Janssen Research Foundation, B-2340 Beerse, Belgium

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 72 KB

95 Real-time characterization of the int

95 Real-time characterization of the interaction of HIV-1-specific inhibitors with their binding site at the HIV-1 reverse transcriptase (RT) using surface plasmon resonance and biosensor technology: R. Pauwels1, B. Persson2, L.G. Fägerstam2, L. Öfås2, K. De Vreese1 P. Van Daele3, Z. Debyser1, R. Bhikhabhai4, B. Strandberg4, J. Desmyter1, P.A.J. Janssen3 and E. De Clercq1 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium; 2Pharmacia Biosensor AB, Uppsala, Sweden; 3Janssen Research Foundation, Beerse, Belgium; and 4Institute of Molecular Biology, Uppsala University, Uppsala, Sweden

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 92 KB